Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age4-18
SponsorRennes University Hospital
About this trial
Chemo- or radiation-induced nausea and vomiting (CRVN) is one of the most frequent and feared side effects.
It is a symptom that is few or not at all evaluated. There is a significant discrepancy between the perception of the CRVN symptom by caregivers and the patient's own experience.
At present, there is no real consensus to manage CRVN with medication, and CRVN relief is also the subject of heterogeneous practices. The importance of primary prevention of CRVN, before starting the first treatment sequence, has been highlighted to optimize the action of antiemetic treatments and limit the risk of anticipated nausea and vomiting (NV).
The investigators' objective is to objectively assess the risk of CRVN in children/adolescents treated for cancer (and thus effectively prevent this symptom).
Eligibility criteria
Qualifiers
Treated in a pediatric onco-hematology center in the GOCE (Grand Ouest Cancer Enfant) inter-region;
Receiving chemotherapy or radiotherapy;
Minor (under 18 years): At least one parent has been informed of the protocol and has not expressed opposition to the child's participation in the study
Adult (more than 18 years): Having received information about the protocol and not having expressed opposition to participating in the study
Disqualifiers
Patients or legal representatives with French understanding difficulties.
Patients or legal representatives subject with legal protection (safeguard of justice, curatorship, guardianship) or deprived of liberty.
Trial design
Treatments tested in this trial
- BARF scale
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov